FOLFIRI Combined with Bevacizumab as First-Line Treatment for Metastatic Colorectal Cancer Patients with Hyperbilirubinemia after UGT1A1 Genotyping

por Yeh, Yung-Sung, Huang, Meng-Lin, Chang, Se-Fen, Chen, Chin-Fan, Hu, Huang-Ming, Wang, Jaw-Yuan
Publicado 2014

High blood sugar levels significantly impact the prognosis of colorectal cancer patients through down-regulation of microRNA-16 by targeting Myb and VEGFR2

por Yang, I-Ping, Tsai, Hsiang-Lin, Huang, Ching-Wen, Lu, Chien-Yu, Miao, Zhi-Feng, Chang, Se-Fen, Juo, Suh-Hang Hank, Wang, Jaw-Yuan
Publicado 2016

Clinical Implication of UGT1A1 Promoter Polymorphism for Irinotecan Dose Escalation in Metastatic Colorectal Cancer Patients Treated with Bevacizumab Combined with FOLFIRI in the F...

por Lu, Chien-Yu, Huang, Ching-Wen, Wu, I-Chen, Tsai, Hsiang-Lin, Ma, Cheng-Jen, Yeh, Yung-Sung, Chang, Se-Fen, Huang, Meng-Lin, Wang, Jaw-Yuan
Publicado 2015

High blood sugar levels but not diabetes mellitus significantly enhance oxaliplatin chemoresistance in patients with stage III colorectal cancer receiving adjuvant FOLFOX6 chemothe...

por Yang, I-Ping, Miao, Zhi-Feng, Huang, Ching-Wen, Tsai, Hsiang-Lin, Yeh, Yung-Sung, Su, Wei-Chih, Chang, Tsung-Kun, Chang, Se-fen, Wang, Jaw-Yuan
Publicado 2019

Clinical characteristics of second primary cancer in colorectal cancer patients: the impact of colorectal cancer or other second cancer occurring first

por Sun, Li-Chu, Tai, Yi-Yun, Liao, Su-Mien, Lin, Tang-Yu, Shih, Ying-Ling, Chang, Se-Fen, Huang, Ching-Wen, Chan, Hon-Man, Huang, Che-Jen, Wang, Jaw-Yuan
Publicado 2014